Prescient Medical

20 articles about Prescient Medical

• Prescient Announces Recent Appointments to the Advisory Senior Team

  7/21/2020

  Prescient hires two new senior members to support its fast-growing Advisory business

• Prescient Metabiomics and the Harvard Chan Microbiome in Public Health Center Collaborate to Advance Research in Colon Cancer Screening

  6/2/2020

  Prescient Metabiomics, a subsidiary of Prescient Medicine Holdings, Inc., announced today a research collaboration with the Harvard Chan Microbiome in Public Health Center (HCMPH Center), a group at Harvard T.H. Chan School

• Prescient Medicine and Erasmus MC Partner to Study Opioid Addiction Risk

  12/10/2019

  The clinical research will be conducted with patients in The Netherlands to confirm that the positive results from research completed in the United States are also found in the Dutch health care system.

• 

  Prescient Healthcare Group Names its Head of Global Analytics

  6/7/2018

  Prescient appoints Dr. Raymond Donninger as Vice President, Head of Global Analytics

• Prescient Medical Presenting at the 5th Annual Canaccord Genuity Cardiovascular Conference

  12/6/2010

• Revolutionary Technology From Prescient Medical to Be Featured at Canaccord Adams Cardiovascular Conference

  11/9/2009

• vProtect Luminal Shield (TM) from Prescient Medical Receives CE Mark

  8/24/2009

• Prescient Medical Receives Frost & Sullivan Product Innovation of the Year Award

  7/27/2009

• Prescient Medical: vProtect(TM) Luminal Shield Stabilizes Vulnerable Plaque

  6/1/2009

• Prescient Medical Achieves Milestones in Clinical Studies of vProtect(TM) Luminal Shield

  3/5/2009

• Prescient Medical Release: vProtect(TM) Luminal Shield Stabilizes Life-Threatening Plaque

  1/15/2009

• Prescient Medical Presents Clinical and Preclinical Findings for vProtect(TM) Luminal Shield and vPredict(TM) Optical Catheter System

  10/9/2008

• Prescient Medical to Present at 2008 UBS Global Life Sciences Conference

  9/22/2008

• Prescient Medical Release: Patient Receives vProtect(TM) Luminal Shield in First-Ever Vulnerable Plaque Clinical Trial

  7/1/2008

• Prescient Medical Achieves Successful Clinical Debut of vProtect(TM) Luminal Shield Novel

  5/29/2008

• Prescient Medical to Present Data on Identification and Treatment of Rupture-Prone Coronary Plaques at EuroPCR 2008

  5/8/2008

• Prescient Medical Acquires New Technology To Detect Inflammation In Coronary Blood Vessels

  11/19/2007

• Prescient Medical Acquires New Technology to Detect Inflammation in Coronary Blood Vessels Time Resolved Light Induced Fluorescence Spectroscopy (TR-LIFS) to be Combined with Other PMI Diagnostic Technologies to Help Prevent Deaths Related to Heart Attack

  11/13/2007

• Prescient Medical Unveils Revolutionary Cath Lab Advances to Cardiology Community

  10/18/2007

• BioAnalytics Group Signs Agreement With Prescient Medical

  8/16/2007